Eleusis SPAC
Eleusis is Ready to Transform Psychedelics into Medicines for Living
1
2
3
eleusis
Significant Market Opportunity
Antidepressant TAM ~$21bn¹ + Psychedelic Care Delivery TAM ~$7bn²
ELE-Psilo - Transforming psilocybin into modern drug therapy for MDD
Anticipated initiation of Phase I study in 1H 2022
Anticipated Phase I results in healthy volunteers and MDD patients in 2H 2022
Andala-Managed Clinics - Bridging "the last mile" of care delivery
Anticipated Cash Flow Positive Clinic Operations in 1H 2023
Source: 1) Global Antidepressants Market Report 2021: COVID-19 Causes a Surge in Demand for Antidepressant Drugs as Mental Health Problems Rise - ResearchAnd Markets.com, Business Wire, April 26, 2021;
2) Partheniou, A. (2021) Psychedelics - A possible disrupter to legacy treatments, Stifel Nicholaus Canada Inc., January 14, 2021 (estimate based in part on data from existing ketamine clinics).
31View entire presentation